Open Access Peer-Reviewed
Original Articles

Troponin I serum levels predict the need of dialysis in incident sepsis patients with acute kidney injury in the intensive care unit

Níveis séricos de troponina predizem a necessidade de diálise em pacientes sépticos com injúria renal aguda renal na unidade de terapia intensiva

Daniel da Almeida Thiengo; Jocemir Ronaldo Lugon; Miguel Luis Graciano

DOI: 10.5935/0101-2800.20150069

ABSTRACT:

INTRODUCTION: Sepsis, an extremely prevalent condition in the intensive care unit, is usually associated with organ dysfunction, which can affect heart and kidney.
OBJECTIVE: To determine whether the cardiac dysfunction and the Troponin I forecast the occurrence of acute renal failure in sepsis.
METHODS: Cardiac dysfunction was assessed by echocardiography and by the serum troponin I levels, and renal impairment by AKIN criteria and the need of dialysis. Twenty-nine patients with incident sepsis without previous cardiac or renal dysfunction were enrolled.
RESULTS AND DISCUSSION: Patients averaged 75.3 ± 17.3 years old and 55% were male. Median APACHE II severity score at ICU admission was 16 (9.7 - 24.2) and mortality rate in 30 days was 45%. On the fifth day, 59% had ventricular dysfunction. Troponin serum levels on day 1 in the affected patients were 1.02 ± 0.6 ng/mL compared with 0.23 ± 0.18 ng/mL in patients without heart dysfunction (p = 0.01). Eighteen out of 29 patients (62%) underwent renal replacement therapy (RRT) and the percent of patients with ventricular dysfunction who required dialysis was higher (94% vs. 16%, p = 0.0001). Values of troponin at day 1 were used to develop a ROC curve to determine their ability to predict the need of dialysis. The area under the curve was 0.89 and the cutoff value was 0.4 ng/mL.
CONCLUSION: We found that an elevation in serum troponin levels, while guarding a relationship with ventricular dysfunction, can be a precious tool to predict the need for dialysis in sepsis patients.

Keywords:
acute kidney injury; sepsis; troponin.

RESUMO:

INTRODUÇÃO: Sepse é uma condição extremamente prevalente na unidade de terapia intensiva, geralmente associada com disfunção orgânica que pode afetar o coração e os rins.
OBJETIVO: Determinar se a disfunção cardíaca e a troponina I preveem a ocorrência de lesão renal aguda na sepse.
MÉTODOS: A disfunção cardíaca foi avaliada por ecocardiografia e pelos níveis de troponina I sérica; e a lesão renal aguda pelos critérios AKIN e necessidade de diálise. Vinte e nove pacientes com sepse foram recrutados.
RESULTADOS E DISCUSSÃO: Os pacientes tinham em média 75,3 ± 17,3 anos e 55% eram do sexo masculino. O escore de gravidade APACHE II médio de internação na UTI foi de 16 (9,7-24,2) e taxa de mortalidade em 30 dias foi de 45%. No quinto dia, 59% tinham disfunção ventricular. O nível sérico de troponina no dia 1 nos pacientes afetados foi de 1,02 ± 0,6 ng/mL em comparação com 0,23 ± 0,18 ng/mL em pacientes sem disfunção cardíaca (p = 0,01). Dezoito dos 29 pacientes (62%) foram submetidos à terapia renal substitutiva e a porcentagem de pacientes com disfunção ventricular que necessitou de diálise foi maior (94% vs. 16%, p = 0,0001) nesse grupo. A área sob uma curva ROC desenhada para prever a necessidade de diálise de acordo com o nível sérico de troponina no dia 1 foi de 0,89 e o valor de corte foi de 0,4 ng/mL.
CONCLUSÃO: Verificou-se que uma elevação nos níveis séricos de troponina pode prever a necessidade de diálise em pacientes sépticos com lesão renal aguda.

Palavras-chave:
lesão renal aguda; sepse; troponina.

FIGURES

Citation: Thiengo DA, Lugon JR, Graciano ML. Troponin I serum levels predict the need of dialysis in incident sepsis patients with acute kidney injury in the intensive care unit. Braz. J. Nephrol. (J. Bras. Nefrol.) 37(4):433. doi:10.5935/0101-2800.20150069
Received: February 23 2015; Accepted: July 01 2015

INTRODUCTION

Despite technological advances, sepsis still remains a major cause of mortality in intensive care units around the world.1 Sepsis is diagnosed by the presence of clinical signs of infections or systemic inflammation regardless of the site of the infection or the causative microbe involved. It can be classified as severe when occur in association with signs of organ dysfunction such as kidney failure or myocardial dysfunction. The kidney is frequently affected in sepsis. Indeed, renal injury is commonly find in severe sepsis and is associated with increased mortality.2 Assessment of renal function in critical care patients is now frequently performed scoring the AKIN criteria which take into account serum creatinine and urinary output.3 Myocardial dysfunction can also occur in sepsis. Accordingly, recent studies have showed that the myocardial dysfunction in sepsis, evaluated by echocardiogram, EKG or troponin measurement, is present in 40% of these patients and is associated with an increase of 20% to 30% in the mortality rate.4,5 The pathophysiology of renal injury in sepsis is multifactorial and may involve crosstalk between the heart and the kidney.

OBJECTIVES

To determine whether the cardiac dysfunction and the Troponin I forecast the occurrence of acute kidney injury or dialysis on patients with sepsis.

METHODS

In this study, we conducted a prospective, longitudinal study in 29 patients with sepsis, admitted in the intensive care unit (ICU) of a private hospital located in the state of Rio de Janeiro - Brazil, in the period of July 2012 to February 2013. The study was approved by the ethical committee of Medical School/University Hospital of Universidade Federal Fluminense. An informed consent was signed by every patient or a relative.

Study subjects

Patients were recruited by systematic sampling as they were being admitted to the ICU, as long as they fulfill the following inclusion criteria: age between 18-90 years, 24 hours or less from the onset of symptoms of sepsis, normal left ventricular function in a transthoracic echocardiogram (TTE) performed in the first 24 hours in the ICU (left ventricular ejection fraction, LVEF > 45%). Admitted patients were excluded from the study if the following exclusion criteria were found: previous either myocardial dysfunction or coronary disease, kidney disease, hepatic failure, use of iodinated contrast media, AIDS, neoplastic disease under treatment with radiotherapy or chemotherapy.

DEFINITIONS AND PROCEDURES

Sepsis was defined by the evidence of bacterial growth in blood, urine or tracheal secretion in addition to at least two of the following criteria: temperature > 38°C or < 36°C, heart rate > 90 beats per minute, respiratory rate > 20 breaths per minute or pCO2 < 32 mmHg, white blood cell count > 12.000 cells/ mm3, or < 4.000 cells/mm3 or > 10% of young cells accordingly to the definition of the Surviving Sepsis Campaign.6 On admission, age, sex, and the severity score APACHE II7 were documented. On the fifth day of hospitalization, a second echocardiogram was performed to discriminate patients without or with ventricular dysfunction, defined by a LVEF value lower than 45%. All patients also had the troponin I serum levels measured in the first, third, fifth and seventh days of hospitalization to assess the role of this biomarker as to the prediction of renal dysfunction. Kidney dysfunction was characterized accordingly to the Acute Kidney Injure Network - AKIN criteria.2 During the period of observation the degree of renal dysfunction as well as the number of patients undergoing dialysis was recorded on a daily basis. All enrolled patients were followed by 30 days or until discharge or death.

Statistical analysis

Results were expressed as mean ± SD if numbers had a normal distribution or, alternatively, as median and interquartile range (IQR). A comparison of continuous variables throughout the study was performed with Student's t test in the case of Gaussian distribution or, alternatively, with Wilcoxon test. Frequencies were compared by chi-square test. The performance of day 1 troponin serum levels as a predictor of RRT was evaluated through the calculation of the area under the receiving operator characteristic curve (ROC). The best troponin I cut-off point discriminating the need for dialysis was obtained from to ROC curve analysis using the Youden method.8 The accuracy of troponin measurement to predict the need of dialysis was also evaluated by calculation of the sensitivity, specificity, positive and negative predictive value, and positive and negative likelihood ratio. Statistical analysis was performed with the statistic software MedCalc 11.4.2.0 (Mariakerke, Oost-Vlaanderen, Belgium). P values <.05 were considered significant.

RESULTS

Twenty-nine patients were included in this analysis after exclusion of three patients, two of them due to withdrawal of the informed consent and one due to a diagnosis of AIDS. The mean age was 75.3 ± 17.3 years and 16 subjects (55%) were male. In view of the high grade of miscegenation of Brazilian population we did not stratified the sample according to race. At the end of the study, 13 deaths (45%) and 9 (31%) discharges were observed with seven patients remaining in the ICU after 30 days of observation. The Charlson comorbidity index varied from 1 to 5, with a mean of 3.2 ± 1.1 and the median APACHE II severity score at ICU admission was 16 (9.7 - 24.2). Regarding myocardial function, the mean LVEF on the first day was 48.2 ± 3.1% and no segmental alterations in ventricular function were found. On the fifth day, 17 patients (59%) had myocardial dysfunction; the mean LVEF of the entire sample at this time was 37.8 ± 5.4%. As expected, troponin values reflected myocardial dysfunction whenever measured during the study. Interestingly, on day 1, the troponin serum levels in patients with ventricular dysfunction on the fifth day were 1.02 ± 0.6 ng/mL, compared with 0.23 ± 0.18 in the remaining ones (p = 0.01). Similarly, the mean serum levels of troponin on the third day was 1.53 ± 0.72 ng/mL in patients with myocardial dysfunction and 0.55 ± 0.25 ng/mL in the group without dysfunction (p = 0.001). Correspondent data on fifth and seventh days were 1.8 ± 0.35 vs. 0.35 ± 0.77 (p = 0.001) and 1.70 ± 0.62 vs. 0.34 ± 0.35 (p = 0.0001) (Table 1). All patients showed an increase in AKIN. Eighteen out of 29 patients (62%) underwent renal replacement therapy (RRT). The mean age among dialysis patients was 80.5 ± 11.7 years and the majority (67%) was male. Thirteen patients who required RRT had a fatal outcome (72%) whereas only 1 out of 11 non-dialysis patients (9%) did so. On average RRT was initiated on the eighth day of ICU admission varying from as early as day 2 to as late as day 15. Accordingly, the higher values of AKIN peaked on the eighth day of observation. As expected, AKIN values were higher in patients who had undergone RRT (1.58 ± 0.55 vs. 0.21 ± 0.11, p = 0.0001). The LVEF in the fifth day was 34.7 ± 4.1% in the group requiring RRT compared with 42.8 ± 3.0% in the group that remained free of dialysis (p < 0.001). From a different perspective, RRT requirement was higher in the group with myocardial dysfunction in TTE performed on the fifth day compared to the group that had no dysfunction. Accordingly, patients with myocardial dysfunction were dialyzed more frequently than patients without dysfunction (94% vs. 16%, p = 0.0001). The group with myocardial dysfunction also exhibited a higher mean AKIN scoring along the ICU stay compared with patients with normal heart function (2.8 ± 0.25 vs. 1.8 ± 0.4, p = 0.03). All these data collectively suggest an association between the presence of myocardial dysfunction and acute renal injury. The mean troponin serum levels were significantly higher in patients who received RRT in each day measured. Values for the first, third, fifth and seventh days (RRT vs. non-RRT) were, respectively: 0.98 ± 0.65 vs. 0.18 ± 0.21, p = 0.008; 1.47 ± 0.75 vs. 0.56 ± 0.26, p = 0.007; 1.78 ± 0.72 vs. 0.28 ± 0.70, p = 0.001; and 1.61 ± 0.26 vs. 0.58 ± 0.09, p < 0.0001 (Table 2). Values of troponin from day 1 were used to develop a ROC curve to determine their ability to predict dialysis. The area under the curve obtained was 0.89. Cutoff value was 0.4 ng/mL (Figure 1). For this value, sensitivity, specificity, positive and negative predictive value, and negative likelihood ratio were 78%, 100%, 100%, 73%, and 0.22. Less certain was the association of troponin and the highest AKIN score reached observed during hospital stay. Accordingly, when we compared the troponin values in three groups divided according to the highest AKIN score reached during hospitalization (= 1, 2, and 3) mean serum troponin levels measured on day 1 were 0.24 ± 0.21 ng/mL, 0.27 ± 0.55 ng/mL, and 1.00 ± 0.64 ng/mL, respectively (p < 0.001 vs. AKIN = 1 or AKIN = 2). Troponin serum levels were also statistically higher in patients with AKIN scoring of 3 on days 3, 5 and 7 (Table 3).

Table 1. Mean values of troponin i according to presence of myocardial dysfunction
  Troponin I(ng/mL)
  Day 1 Day 3 Day 5 Day 7
Without myocardial dysfunction 0.23 ± 0.18 0.55 ± 0.25 0.77 ± 0.35 0.62 ± 0.35
With myocardial dysfunction# 1.02 ± 0.6* 1.53 ± 0.72 &1.8 ± 0.35 &1.70 ± 0.34$

* Defined as left ventricular ejection fraction < 45% on the 5th day of ICU.

*p < 0.01,

& p < 0.001,

$ p < 0.0001.

Table 2. Mean values of troponin i according to the need of renal replacement therapy (RRT)
Need of RRT Troponin I (ng/mL)  
Day 1 Day 3 Day 5 Day 7
Yes 0.21 ± 0.18 0.56 ± 0.26 0.70 ± 0.28 0.58 ± 0.09
No 0.98 ± 0.65* 1.47 ± 0.75* 1.78 ± 0.72* 1.61 ± 0.26#

RRT, renal replacement therapy.

* p < 0.001,

# p < 0.0001.

Table 3. Mean values of Troponin I according to the akin score
  Troponin I (ng/mL)  
  Day 1 Day 3 Day 5 Day 7
AKIN 1 0.24 ± 0.18 0.59 ± 0.26 0.72 ± 0.30 0.59 ± 0,34
AKIN 2 0.27 ± 0.23 0.50 ± 0.26 0.67 ± 0.12 0.43 ± 0.06
AKIN 3 1.00 ± 0.63* 1.58 ± 0.72* 1.93 ± 0.64* 1.79 ± 1.00*

* p < 0.05 vs. AKIN 1 and AKIN 2. AKIN, Acute Kidney Injury Network score.

DISCUSSION

This study was designed to evaluate the interplay between myocardial dysfunction, serum troponin levels and renal function at the early phase of sepsis in the intensive care unit. In this prospective observational study, conducted from July 2012 to February 2013, 29 patients were included. Patients were derived from the emergency or surgical room, were unaware of cardiac disease and had sepsis diagnosed within the last 24 hours, representing the typical incident patient with sepsis in the ICU. Myocardial failure is a common organic dysfunction in sepsis.9,10 Accordingly, it has already been reported that impaired cardiac function is frequent in septic patients and considerably increases mortality rate in ICU patients.4 A broad spectrum of ventricular impairment can be found in sepsis, ranging from diastolic dysfunction to severe systolic dysfunction.11 Myocardial involvement in sepsis, regardless of the pathophysiological mechanisms can be detected by abnormalities in EKG or TTE, particularly decrement of ejection fraction,11 and also by elevation of serum biomarkers like troponin I and BNP.12 The initial myocardial injury characterized by elevated serum troponin eventually leads to organ dysfunction11 in most of these patients expressed as a fall in the LVEF.11 The results of the present study confirm the relationship between elevated troponin levels and the development of myocardial dysfunction in septic patients.12,13 The sepsis associated myocardial dysfunction appears to be in some way related to the development of renal injury in such patients.14 This relationship was confirmed in the current study when the ventricular function of patients requiring RRT was found to be lower. It is universally acknowledged that the golden standard tool to verify such relationship, the TTE, requires trained personnel and equipment that is not readily available at the ICU scenario imposing limitation to this diagnosis in clinical practice. On the other hand, troponin serum levels determination carries no such inconvenience as it is a routine exam in most intensive care units. Our results strongly suggest that troponin serum levels may indeed predict the development of renal dysfunction and the need of RRT in sepsis patients. The analysis of the ROC curve allowed us to infer the cut-off value for the serum level of troponin. Accordingly, values greater than 0.4 mg/dL at day 1 of the diagnosis of sepsis accurately predicted the need of dialysis. It is known that troponins accumulate in renal injury lessening their accuracy to predict coronary events in patients with renal injury, either acute, chronic or nondialytic.15-17

However, Troponin I is less predictably increased in renal insufficiency and its level usually is not affected by the renal functional status. Moreover, in the current study, it is implausible that troponin I levels reflects renal function as it increase preceded the reduction in glomerular filtration rate or the decrease in urinary output. Perhaps inspired in the concept of hepatorenal syndrome the term cardiorenal syndrome has been coined.18 Contrariwise to the first entity however, the so called cardiorenal syndromes lack a common pathophysiological background and are better understood as a collection of different entities affecting both the kidneys and the heart. Sepsis would be categorized as CRS type 5 in which both the kidney and the heart are contemporaneously affected by the same pathological process. It should be remembered, nevertheless, that intravascular volume contraction brought by systemic vasodilation as well as diminished myocardial contractility induced by the inflammatory milieu are sufficient reasons to trigger renal malperfusion and AKI, at least in the absence of fluid resuscitation and early management of the septic syndrome. The fact that the current series involves patients in the early phase of sepsis renders the hypothesis of renal injury caused by hypoperfusion highly unlikely. Moreover, the finding of Langenberg et al.19 that hyperdynamic sepsis in large mammals involves renal hyperemia instead of ischemia heightens the probability that AKI in the scenario of sepsis is not determined by renal hypoperfusion. It is more conceivable that the systemic inflammatory environment triggers concomitantly both renal and cardiac dysfunction in the context of septic multiple organ dysfunction. However, it is intriguing how experimental ischemic AKI can determine distant cardiac dysfunction denoting significant crosstalk between the kidneys and heart. In that specific study, renal ischemia, incapable of producing oliguria or uremia, induced long distance heart damage characterized by altered echocardiography, as well as leukocyte infiltration and apoptosis induction in the cardiac tissue. Additionally, it was shown that these abnormalities were partially mediated by TNF-alfa a known mediator of the inflammatory cascade.20 In the present study echocardiographic abnormalities were observed earlier than the AKI diagnosis was made either through the AKIN score or by the commencement of RRT. As undisputed clinical heart failure was never diagnosed in our patients it is very unlikely that low cardiac output triggered renal injury. Naturally, both organs might be involved at the same time by the inflammatory/cytopathic phenomena associated with sepsis; however, it is tempting to speculate that initial renal damage could eventually lead to cardiac damage. Of course, in the absence of an earlier marker of renal injury, such reasoning is pure speculation, at best. Not surprisingly, there has been a widespread search for such early markers of renal injury by the nephrology and renal scientists' community. Suspicious they are that clinical diagnosis of AKI is a late phenomenon, they longed for a biomarker able to predict renal outcome in AKI. Accordingly, NGAL, KIM-1, IL-18 and several other molecules are now considered putative markers of renal dysfunction.21-24 All those markers perform fairly well in predicting AKI in timed events such as cardiac surgery and contrast media administration. However, in the setting of a more blurred insult (in the timeline) to the kidneys, such as the case of sepsis, the same biomarkers perform poorly. Interestingly, in the search of such gold standard biomarker scientists used to say they were looking for the "troponin" of acute kidney injury.25,26 It would be extremely ironic that in the end troponin itself resulted being such Holy Grail of nephrology. Regardless of the pathophysiological mechanisms involved, the results shown here may have an important and practical clinical implication as troponin I might be used as a biomarker of AKI in sepsis. Most importantly, and which cannot be underemphasized, troponin I not only predict "soft" outcomes such as minor elevations of serum creatinine levels, but actually predict "hard" ones like necessity of dialysis and even mortality. The fact that this result was observed in such a complex disease as sepsis renders it even more compelling.

CONCLUSION

In conclusion, the measurement of troponin I seem to be able to measure accurately the presence of cardiac dysfunction in septic patients and predict renal dysfunction in these same patients. Of course, this important clinical observation has to be confirmed by larger studies.

REFERENCES

Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10. PMID: 11445675Link PubMedLink DOI
Gopaluni S, Lines S, Lewington AJ. Acute kidney injury in critically ill patient. Curr Anaesthesia Crit Care 2010;21:60-4. DOI:http://dx.doi.org/10.1016/j.cacc.2009.09.006Link DOI
Levin A, Kellum JA, Mehta RL; Acute Kidney Injury Network (AKIN). Acute kidney injury: toward an integrated understanding through development of a research agenda. Clin J Am Soc Nephrol 2008;3:862-3. DOI: http://dx.doi.org/10.2215/CJN.04841107Link DOILink PubMed
Dhainaut JF, Cariou A, Laurent I. Myocardial dysfunction in sepsis. Sepsis 2000;4:89-97. DOI: http://dx.doi.org/10.1023/A:1011446602717Link DOI
Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003;41:2004-9. PMID: 12798573 DOI: http://dx.doi.org/10.1016/S0735-1097(03)00421-2Link PubMedLink DOI
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al.; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637. DOI: http://dx.doi.org/10.1097/CCM.0b013e31827e83afLink DOILink PubMed
Larvin M, Mcmohon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989;2:201-5. DOI:http://dx.doi.org/10.1016/S0140-6736(89)90381-4Link DOILink PubMed
Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285-93. PMID: 3287615 DOI: http://dx.doi.org/10.1126/science.3287615Link PubMedLink DOI
Ognibene FP, Parker MM, Natanson C, Shelhamer JH, Parrillo JE. Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest 1988;93:903-10. DOI: http://dx.doi.org/10.1378/chest.93.5.903Link DOILink PubMed
Cunnion RE, Parrillo JE. Myocardial dysfunction in sepsis. Crit Care Clin 1989;5:99-118.Link PubMed
Poelaert J, Declerck C, Vogelaers D, Colardyn F, Visser CA. Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997;23:553-60. DOI: http://dx.doi.org/10.1007/s001340050372Link DOILink PubMed
John J, Woodward DB, Wang Y, Yan SB, Fisher D, Kinasewitz GT, et al. Troponin-I as a prognosticator of mortality in severe sepsis patients. J Crit Care 2010;25:270-5. DOI: http://dx.doi.org/10.1016/j.jcrc.2009.12.001Link DOILink PubMed
Røsjø H, Varpula M, Hagve TA, Karlsson S, Ruokonen E, Pettilä V, et al.; FINNSEPSIS Study Group. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med 2011;37:77-85. DOI:http://dx.doi.org/10.1007/s00134-0102051-xLink DOILink PubMed
Chelazzi C, Villa G, De Gaudio AR. Cardiorenal syndromes and sepsis. Int J Nephrol 2011;2011:652967. PMID: 21603105 DOI:http://dx.doi.org/10.4061/2011/652967Link PubMed
Song D, de Zoysa JR, Ng A, Chiu W. Troponins in acute kidney injury. Ren Fail 2012;34:35-9. DOI: http://dx.doi.org/10.3109/0886022X.2011.623440Link DOILink PubMed
Beciani M, Tedesco A, Violante A, Cipriani S, Azzarito M, Sturniolo A, et al. Cardiac troponin I (2nd generation assay) in chronic haemodialysis patients: prevalence and prognostic value. Nephrol Dial Transplant 2003;18:942-6. DOI: http://dx.doi.org/10.1093/ndt/gfg057Link DOILink PubMed
Abbas NA, John RI, Webb MC, Kempson ME, Potter AN, Price CP, et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem 2005;51:2059-66. DOI: http://dx.doi.org/10.1373/clinchem.2005.055665Link DOILink PubMed
Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 2008;52:1527-39. PMID: 19007588 DOI:http://dx.doi.org/10.1016/j.jacc.2008.07.051Link PubMedLink DOI
Langenberg C, Wan L, Egi M, May CN, Bellomo R. Renal blood flow in experimental septic acute renal failure. Kidney Int 2006;69:1996-2002. PMID:16641923 DOI: http://dx.doi.org/10.1038/sj.ki.5000440Link PubMedLink DOI
Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003;14:1549-58. DOI:http://dx.doi.org/10.1097/01.ASN.0000064946.94590.46Link DOILink PubMed
McCullough PA, Bouchard J, Waikar SS, Siew ED, Endre ZH, Goldstein SL, et al. Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013;182:5-12. PMID: 23689652Link PubMed
Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest Suppl 2008;241:78-83. PMID: 18569971 DOI: http://dx.doi.org/10.1080/00365510802145059Link PubMedLink DOI
Soto K, Papoila AL, Coelho S, Bennett M, Ma Q, Rodrigues B, et al. Plasma NGAL for the diagnosis of AKI in patients admitted from the emergency department setting. Clin J Am Soc Nephrol 2013;8:2053-63. DOI: http://dx.doi.org/10.2215/CJN.12181212Link DOILink PubMed
Hall IE, Coca SG, Perazella MA, Eko UU, Luciano RL, Peter PR, et al. Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis. Clin J Am Soc Nephrol 2011;6:2740-9. DOI: http://dx.doi.org/10.2215/CJN.04960511Link DOILink PubMed
Abdallah E, Waked E, Al-Helal B, Asad R, Nabil M, Harba T. Novel troponin-like biomarkers of acute kidney injury. Saudi J Kidney Dis Transpl 2013;24:1111-24. DOI: http://dx.doi.org/10.4103/1319-2442.121267Link DOILink PubMed
Devarajan P. Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton) 2010;15:419-28. DOI: http://dx.doi.org/10.1111/j.1440-1797.2010.01317.xLink DOILink PubMed

© 2017 All rights reserved